Hydrocephalus Shunts Market Size, Share Industry Trends 2028

The hydrocephalus shunts market is expected to grow US$ 360.01 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.     

Hydrocephalus is a fluid build-up in the brain, which puts pressure on the brain. It is common in older adults and infants. Headache, impaired vision, cognitive difficulties, coordination ability loss, and incontinence are among the symptoms experienced by patients with hydrocephalus. It may cause head enlargement in infants. A hydrocephalus shunt is the surgical insertion of a drainage system that helps drain out excess fluid from the brain.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Hydrocephalus Shunts Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

The hydrocephalus shunts market is segmented on the basis of age group, type, product, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market with an emphasis on parameters such as market trends and market dynamics. It also highlights the competitive analysis of the globally leading players in the hydrocephalus shunts market.

Market Insights

Increasing Prevalence of Hydrocephalus Boosts Hydrocephalus Shunts Market

Hydrocephalus is more prevalent in children and infants than adult population worldwide. Additionally, the disease is also prevalent in people aged 60 and above. According to the Hydrocephalus Association, the disease affects over 1 million Americans. Additionally, the incidence rate of hydrocephalus in the US is 1 in every 770 babies.

According to the article "Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis," published in the Journal of Neurosurgery (JNS) in 2019, low-income and middle-income countries, particularly those in Africa and Latin America, incur the most significant burden of hydrocephalus. The article also states that Sub-Saharan Africa witnessed an annual incidence of more than 225,000 new cases of infant hydrocephalus, i.e., 750 new cases per 100,000 live births. Moreover, in a European cohort, the incidence rate was estimated at 110 cases of infantile hydrocephalus per 100,000 live births.

The treatment approach of hydrocephalus highly focuses on managing CSF through medical devices named shunts. The shunt systems remove excess cerebrospinal fluid from the brain and divert it to other body parts, wherein it is absorbed as a part of the circulatory process. Thus, the high incidence of hydrocephalus leads drives the demand for hydrocephalus shunts, thereby boosting the hydrocephalus market growth

Product Insights

Based on the product, the hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment held the largest market share in 2021, and it is also anticipated to register the highest CAGR of 3.6% during the forecast period. The market for hydrocephalus valves is further bifurcated into adjustable pressure valves and fix pressure valves. 

Type Insights

Based on type, the hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculoatrial, ventriculo-pleural, and lumbo-peritoneal. In 2021, the ventriculo-peritoneal segment held the largest share of the market. Moreover, the market for this segment is expected to grow at a significant CAGR of 3.7% during the forecast period.

Age Group Insights

Based on age group, the hydrocephalus shunts market is segmented into pediatric and adults. In 2021, the pediatric segment held a larger share of the market. It is further estimated to register a significant CAGR of 3.5% during the forecast period.

Hydrocephalus Shunts Market Regional Insights

The regional trends and factors influencing the Hydrocephalus Shunts Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Hydrocephalus Shunts Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Hydrocephalus Shunts Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Hydrocephalus Shunts Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Hydrocephalus Shunts Market are:

1. B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)
2. Sophysa
3. HpBio Próteses, inc.
4. Integra LifeSciences Holdings Corporation
5. KANEKA MEDIX CORP.

Disclaimer: The companies listed above are not ranked in any particular order.

End User Insights

Based on end user, the hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2021, and it is expected to register the highest CAGR of 3.8% during the forecast period.

Organic strategies such as product launches and approvals are highly adopted growth strategies by companies in the hydrocephalus shunts market. A few of the recent key market developments are listed below.

• In May 2020, Aesculap, Inc. in partnership with The Christoph Miethke GmbH & Co. KG (MIETHKE) announced the launch of the M.blue valve in the US. The M.blue valve features advanced gravitational technology, which is incorporated with a fixed differential pressure unit in one valve. It helps to provide a simple and position-dependent solution
• In July 2019, Integra LifeSciences announced the acquisition of Arkis Biosciences Inc., a privately held company that offers a portfolio of neurosurgical devices, such as catheters. The acquisition of Arkis Biosciences strengthened Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.

Company Profiles

• B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)
• Sophysa
• HpBio Próteses, inc.
• Integra LifeSciences Holdings Corporation
• KANEKA MEDIX CORP.
• Medtronic Plc
• Natus Medical Incorporated
• Spiegelberg GmbH & Co. KG
• Desu Medical